Screener
BioMarin Pharmaceuticals BMRN Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from BioMarin Pharmaceuticals’s reported figures.
The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001048477-26-000016
FAQ
- What is BioMarin Pharmaceuticals's free cash flow?
- BioMarin Pharmaceuticals (BMRN) reported free cash flow of $139.29M in Q2 2026.
- How has BioMarin Pharmaceuticals's free cash flow changed year-over-year?
- BioMarin Pharmaceuticals's free cash flow decreased by 17.2% year-over-year, from $168.17M to $139.29M.
- What is the long-term trend for BioMarin Pharmaceuticals's free cash flow?
- Over 2 years (2021 to 2025), BioMarin Pharmaceuticals's free cash flow has grown at a 78.9% compound annual growth rate (CAGR), from $226.52M to $724.96M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about BioMarin Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude